Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$28.64+0.02 (+0.07%)
Close on Nov 13, 2026Market cap $1.71BP/E –Yield –
Kestra Medical Technologies gross margin
Gross margin is gross profit as a percentage of revenue.
Kestra Medical Technologies's gross margin for the twelve months ending Jul 31, 2026 was 53.9%. For fiscal 2026 it was 51.4%, against 40.5% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | 51.4% | +10.9 |
| FY2025 | Apr 30, 2025 | 40.5% | +39.2 |
| FY2024 | Apr 30, 2024 | 1.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | 56.5% | +10.8 |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | 54.8% | +10.5 |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | 52.6% | +9.2 |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | 50.6% | +11.0 |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | 45.7% | +12.8 |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | 44.3% | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | 43.4% | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | 39.6% | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | 32.9% | – |
See a number that looks wrong?